These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26056798)

  • 1. Predicting, Monitoring, and Managing Hypercalcemia Secondary to 13-Cis-Retinoic Acid Therapy in Children With High-risk Neuroblastoma.
    Chen SC; Murphy D; Sastry J; Shaikh MG
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):477-81. PubMed ID: 26056798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercalcemia and 13-cis-retinoic acid in post-consolidation therapy of neuroblastoma.
    Marabelle A; Sapin V; Rousseau R; Periquet B; Demeocq F; Kanold J
    Pediatr Blood Cancer; 2009 Feb; 52(2):280-3. PubMed ID: 18839433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcemia induced by 13 cis-retinoic acid in patients with neuroblastoma.
    Mugishima H; Chin M; Suga M; Schichino H; Ryo N; Nakamura M; Harada K
    Pediatr Int; 2008 Apr; 50(2):235-7. PubMed ID: 18353067
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid.
    Villablanca JG; Khan AA; Avramis VI; Reynolds CP
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):410-5. PubMed ID: 8214363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia induced by 13-cis-retinoic acid in a patient with neuroblastoma.
    Belden TL; Ragucci DP
    Pharmacotherapy; 2002 May; 22(5):645-8. PubMed ID: 12013365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia and osteoblastic lesions induced by 13-Cis-retinoic acid mimicking relapsed neuroblastoma.
    Cross SF; Dalla Pozza L; Munns CF
    Pediatr Blood Cancer; 2009 Oct; 53(4):666-8. PubMed ID: 19492317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
    Villablanca JG; Khan AA; Avramis VI; Seeger RC; Matthay KK; Ramsay NK; Reynolds CP
    J Clin Oncol; 1995 Apr; 13(4):894-901. PubMed ID: 7707116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia is a frequent side effect of 13-cis-retinoic acid treatment in patients with high-risk neuroblastoma.
    Hoemberg M; Schwenzfeur R; Berthold F; Simon T; Hero B
    Pediatr Blood Cancer; 2022 Feb; 69(2):e29374. PubMed ID: 34569150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of advanced bone age in a cohort of patients who received cis-retinoic acid for high-risk neuroblastoma.
    Hobbie WL; Mostoufi SM; Carlson CA; Gruccio D; Ginsberg JP
    Pediatr Blood Cancer; 2011 Mar; 56(3):474-6. PubMed ID: 21072832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
    Nau H
    J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy.
    Kohler JA; Imeson J; Ellershaw C; Lie SO
    Br J Cancer; 2000 Nov; 83(9):1124-7. PubMed ID: 11027423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing and managing the side effects of isotretinoin.
    Brelsford M; Beute TC
    Semin Cutan Med Surg; 2008 Sep; 27(3):197-206. PubMed ID: 18786498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral side effects of isotretinoin chronic intake.
    Rodrigues MT; Albuquerque DF; Capelozza AL; Faria FA; Santos CF
    N Y State Dent J; 2008; 74(4):36-9. PubMed ID: 18788179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoid-induced hypercalcemia in a patient with kaposi sarcoma associated with acquired immunodeficiency syndrome.
    Aboulafia DM; Bundow D; Weaver C; Yokum RC
    Am J Clin Oncol; 1998 Oct; 21(5):513-7. PubMed ID: 9781612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premature physeal closure following 13-cis-retinoic acid and prolonged fenretinide administration in neuroblastoma.
    Steineck A; MacKenzie JD; Twist CJ
    Pediatr Blood Cancer; 2016 Nov; 63(11):2050-3. PubMed ID: 27399265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group.
    Finklestein JZ; Krailo MD; Lenarsky C; Ladisch S; Blair GK; Reynolds CP; Sitarz AL; Hammond GD
    Med Pediatr Oncol; 1992; 20(4):307-11. PubMed ID: 1608352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotretinoin (13-cis-retinoic acid)-associated premature ventricular contractions.
    Kiliç E; Sahin M; Sahin S; Ozer S
    Turk J Pediatr; 2009; 51(4):387-8. PubMed ID: 19950851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uses and complications of isotretinoin therapy.
    Ellis CN; Krach KJ
    J Am Acad Dermatol; 2001 Nov; 45(5):S150-7. PubMed ID: 11606947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13-cis-retinoic acid-associated bone marrow edema in neuroblastoma.
    Sato Y; Kuwashima S; Kurosawa H; Sugita K; Fukushima K; Arisaka O
    Pediatr Blood Cancer; 2012 Sep; 59(3):589-90. PubMed ID: 22354520
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacogenetics of 13-cis retinoic acid in Indian high-risk neuroblastoma patients.
    Gota V; Chinnaswamy G; Vora T; Rath S; Yadav A; Gurjar M; Veal G; Kurkure P
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):763-8. PubMed ID: 27541143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.